Efficacy and Safety of XAV-19 for the Treatment of Moderate-to-severe COVID-19

A Study to Assess the Efficacy and Safety of XC221 in Patients With COVID-19

NCT04487574 ·Status: COMPLETED ·Phase: PHASE3

A Phase 2 Study of APX-115 in Hospitalized Patients With Confirmed Mild to Moderate COVID-19.

NCT04880109 ·Status: TERMINATED ·Phase: PHASE2

A Study to Evaluate the Safety, Tolerability and Efficacy of XC221 in Patients With Uncomplicated Influenza or Other Acute Viral Upper Respiratory Infections

NCT05030324 ·Status: COMPLETED ·Phase: PHASE2

Efficacy, Safety, Tolerability of AXA1125 in Fatigue After COVID-19 Infection

NCT05152849 ·Status: COMPLETED ·Phase: PHASE2

A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients With COVID-19 Who Are Not Hospitalized But Are at Risk For Severe Disease

NCT06679140 ·Status: RECRUITING ·Phase: PHASE3

DUR-928 in Subjects With SARS-CoV-2 With Acute Lung, Liver or Kidney Injury

NCT04447404 ·Status: TERMINATED ·Phase: PHASE2

Study of Varespladib in Patients Hospitalized With Severe COVID-19

NCT04969991 ·Status: TERMINATED ·Phase: PHASE2

Randomized, Controlled, Double-blind Clinical Trial Comparing the Efficacy and Safety of Chemoprophylaxis With Hydroxychloroquine in Patients Under Biological Treatment and / or JAK Inhibitors in the Prevention of SARS-CoV-2 Infection

NCT04330495 ·Status: WITHDRAWN ·Phase: PHASE4

Efficacy of Amantadine Treatment in COVID-19 Patients

NCT04952519 ·Status: TERMINATED ·Phase: PHASE3

Efficacy and Safety of hzVSFv13 in Patients With COVID-19 Pneumonia

NCT04679350 ·Status: TERMINATED ·Phase: PHASE2

Safety and Efficacy of Tofacitinib in Hospitalized Participants With COVID-19 Pneumonia Who Are Receiving Standard of Care Therapy

NCT04412252 ·Status: WITHDRAWN ·Phase: PHASE2

A Study of Hydroxycholoroquine Compared to Placebo as Treatment for People With COVID-19

NCT04379492 ·Status: WITHDRAWN ·Phase: PHASE2

Hydroxychloroquine Versus Placebo in COVID-19 Patients at Risk for Severe Disease

NCT04325893 ·Status: TERMINATED ·Phase: PHASE3

A Study to Evaluate the Safety, Pharmacokinetics (PK), and Efficacy of TAK-671 for the Treatment of Coronavirus Disease (COVID) 2019 in Adults

NCT04464460 ·Status: WITHDRAWN ·Phase: PHASE1

Pathogenesis of BTK-mediated Hyper-Inflammatory Responses in COVID-19 (RESPOND)

NCT04394884 ·Status: WITHDRAWN

Study to Assess Efficacy and Safety of XC221 200 mg in the Treatment of Influenza or Other ARVI

NCT03830905 ·Status: COMPLETED ·Phase: PHASE2

A Study of LY3127804 in Participants With COVID-19

NCT04342897 ·Status: TERMINATED ·Phase: PHASE2

Study to Assess Efficacy and Safety of XC221 in the Treatment of Influenza and Other Acute Respiratory Viral Infections

NCT03455491 ·Status: COMPLETED ·Phase: PHASE2

Duvelisib to Combat COVID-19

NCT04372602 ·Status: COMPLETED ·Phase: PHASE2

The Phase 2 Study to Evaluate the Safety and Efficacy of Clevudine in Patients With Moderate COVID-19

NCT04347915 ·Status: COMPLETED ·Phase: PHASE2

Safety and Preliminary Efficacy Study of GX-I7 in Patients With COVID-19

NCT04730427 ·Status: TERMINATED ·Phase: PHASE1

Chemoprophylaxis of SARS-CoV-2 Infection (COVID-19) in Exposed Healthcare Workers

NCT04328285 ·Status: TERMINATED ·Phase: PHASE3

"Study of the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of the Drug B10-FC After Single Administration to Adult Patients".

NCT07156864 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1

Study to Evaluate the Effects of RO7496998 (AT-527) in Non-Hospitalized Adult and Adolescent Participants With Mild or Moderate COVID-19

NCT04889040 ·Status: TERMINATED ·Phase: PHASE3

Study to Assess Safety, Tolerability and Pharmacokinetics of XC221 in Healthy Volunteers

NCT03459391 ·Status: COMPLETED ·Phase: PHASE1